Suggestions for Regulatory Agency Approval of Second-Line Systemic Therapy for Metastatic Transitional Cell Carcinoma

被引：7

作者：

Sonpavde, Guru ^{[1
,2
,9
]}

Rosenberg, Jonathan E. ^{[3
,4
]}

Hahn, Noah M. ^{[5
]}

Galsky, Matthew D. ^{[6
]}

Bangs, Rick ^{[7
]}

Sternberg, Cora N. ^{[8
]}

Vogelzang, Nicholas J. ^{[6
]}

机构：

[1] Texas Oncol, Houston, TX USA

[2] Baylor Coll Med, Houston, TX 77030 USA

[3] Dana Farber Canc Inst, Boston, MA 02115 USA

[4] Harvard Univ, Sch Med, Boston, MA USA

[5] Indiana Univ, Ctr Canc, Indianapolis, IN 46204 USA

[6] Compehens Canc Ctr Nevada, Las Vegas, NV USA

[7] SW Oncol Grp, Rochester Hills, MI USA

[8] San Camillo Forlanini Hosp, Rome, Italy

[9] Vet Affairs Med Ctr, Houston, TX 77030 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 13期

关键词：

COOPERATIVE-ONCOLOGY-GROUP; PHASE-II TRIAL; ADVANCED UROTHELIAL CARCINOMA; PLATINUM-CONTAINING REGIMEN; LUNG-CANCER; SUPPORTIVE CARE; CHEMOTHERAPY; PACLITAXEL; GEMCITABINE; VINFLUNINE;

D O I：

10.1200/JCO.2009.27.1114

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：E205 / E207

页数：3

共 25 条

[1] Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy [J].

Bajorin, DF ;

Dodd, PM ;

Mazumdar, M ;

Fazzari, M ;

McCaffrey, JA ;

Scher, HI ;

Herr, H ;

Higgins, G ;

Boyle, MG .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (10) :3173-3181

[2] Southwest oncology group phase II study of irinotecan in patients with advanced transitional cell carcinoma of the urothelium that progressed after platinum-based chemotherapy [J].

Beer, Tomasz M. ;

Goldman, Bryan ;

Nichols, Craig R. ;

Petrylak, Daniel P. ;

Agarwal, Manoj ;

Ryan, Christopher W. ;

Crawford, E. David .

CLINICAL GENITOURINARY CANCER, 2008, 6 (01) :36-39

[3] Phase III Trial of Vinflunine Plus Best Supportive Care Compared With Best Supportive Care Alone After a Platinum-Containing Regimen in Patients With Advanced Transitional Cell Carcinoma of the Urothelial Tract [J].

Bellmunt, Joaquim ;

Theodore, Christine ;

Demkov, Tomasz ;

Komyakov, Boris ;

Sengelov, Lisa ;

Daugaard, Gedske ;

Caty, Armelle ;

Carles, Joan ;

Jagiello-Gruszfeld, Agnieszka ;

Karyakin, Oleg ;

Delgado, Francois-Michel ;

Hurteloup, Patrick ;

Morsli, Nassim ;

Salhi, Yacine ;

Culine, Stephane ;

von der Maase, Hans .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (27) :4454-4461

[4] Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer [J].

Blum, JL ;

Jones, SE ;

Buzdar, AU ;

LoRusso, PM ;

Kuter, I ;

Vogel, C ;

Osterwalder, B ;

Burger, HU ;

Brown, CS ;

Griffin, T .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (02) :485-493

[5] Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study [J].

Ciuleanu, Tudor ;

Brodowicz, Thomas ;

Zielinski, Christoph ;

Kim, Joo Hang ;

Krzakowski, Maciej ;

Laack, Eckart ;

Wu, Yi-Long ;

Bover, Isabel ;

Begbie, Stephen ;

Tzekova, Valentina ;

Cucevic, Branka ;

Pereira, Jose Rodrigues ;

Yang, Sung Hyun ;

Madhavan, Jayaprakash ;

Sugarman, Katherine P. ;

Peterson, Patrick ;

John, William J. ;

Krejcy, Kurt ;

Belani, Chandra P. .

LANCET, 2009, 374 (9699) :1432-1440

[6] A phase II study of vinflunine in bladder cancer patients progressing after first-line platinum-containing regimen [J].

Culine, S. ;

Theodore, C. ;

De Santis, M. ;

Bui, B. ;

Demkow, T. ;

Lorenz, J. ;

Rolland, F. ;

Delgado, F. -M. ;

Longerey, B. ;

James, N. .

BRITISH JOURNAL OF CANCER, 2006, 94 (10) :1395-1401

[7] Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial [J].

Demetri, George D. ;

van Oosterom, Allan T. ;

Garrett, Christopher R. ;

Blackstein, Martin E. ;

Shah, Manisha H. ;

Verweij, Jaap ;

McArthur, Grant ;

Judson, Ian R. ;

Heinrich, Michael C. ;

Morgan, Jeffrey A. ;

Desai, Jayesh ;

D Fletcher, Christopher ;

George, Suzanne ;

Bello, Carlo L. ;

Huang, Xin ;

Baum, Charles M. ;

Casali, Paolo G. .

LANCET, 2006, 368 (9544) :1329-1338

[8] Paclitaxel in advanced urothelial carcinoma: Its role in patients with renal insufficiency and as salvage therapy [J].

Dreicer, R ;

Gustin, DM ;

See, WA ;

Williams, RD .

JOURNAL OF UROLOGY, 1996, 156 (05) :1606-1608

[9] Phase 2 trial of epothilone B analog BMS-247550 (ixabepilone) in advanced carcinoma of the Urothelium (E3800) - A trial of the Eastern Cooperative Oncology Group [J].

Dreicer, Robert ;

Li, Shuli ;

Manola, Judith ;

Haas, Naomi B. ;

Roth, Bruce J. ;

Wilding, George .

CANCER, 2007, 110 (04) :759-763

[10] Overall survival of patients with advanced colorectal cancer correlates with availability of fluorouracil, irinotecan, and oxaliplatin regardless of whether doublet or single-agent therapy is used first line [J].

Grothey, A ;

Sargent, D .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (36) :9441-9442

← 1 2 3 →